Euclid Advisors’s Xylem XYL Stock Holding History

Euclid Advisors’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-33,475	Closed	-$1.5M	–	472
2016 Q2	$1.5M	Sell	33,475 -9,560	-22%	-$415K	0.07%	304
2016 Q1	$1.76M	Buy	43,035 +8,085	+23%	+$298K	0.07%	293
2015 Q4	$1.28M	Buy	+34,950	New	+$1.26M	0.04%	311
2015 Q3	–	Sell	-64,290	Closed	-$2.38M	–	446
2015 Q2	$2.38M	Buy	+64,290	New	+$2.34M	0.05%	296
2014 Q4	–	Sell	-119,330	Closed	-$4.24M	–	509
2014 Q3	$4.24M	Buy	119,330 +13,614	+13%	+$506K	0.03%	394
2014 Q2	$4.13M	Sell	105,716 -32,340	-23%	-$1.21M	0.03%	393
2014 Q1	$5.03M	Buy	138,056 +42,240	+44%	+$1.54M	0.04%	315
2013 Q4	$3.31M	Sell	95,816 -8,560	-8%	-$275K	0.03%	434
2013 Q3	$2.92M	Buy	104,376 +21,496	+26%	+$573K	0.03%	411
2013 Q2	$2.23M	Buy	+82,880	New	+$2.29M	0.03%	429

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Euclid Advisors's XYL Position: Q3 2016 in Review

Euclid Advisors sold out of Xylem (XYL) in Q3 2016, closing a stake of 33,475 shares — an estimated $1.5M sold.

Euclid Advisors first reported a position in XYL in Q2 2013 and held it in 10 quarters. The position peaked at $5.03M in Q1 2014. 522 funds tracked by Wall St. Rank hold XYL as of Q3 2016.

Euclid Advisors reported no remaining Xylem position as of Q3 2016 after selling out during the quarter.
Euclid Advisors sold 33,475 Xylem shares in Q3 2016, an estimated $1.5M.
Euclid Advisors first reported a position in Xylem in Q2 2013 and held it in 10 quarters.
Euclid Advisors's Xylem position peaked at $5.03M in Q1 2014.
522 funds tracked by Wall St. Rank held Xylem as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.